Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | RARB | P10826 | 1/20 | 0.45 |
| ▸ | RARG | P13631 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.40 |
| ▸ | GABRE | P78334 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31403398 | 0.97 | KIF11 (0.50) | KIF11TSHRLMNATYRRARB | |
| SCHEMBL27635840 | 0.93 | KIF11 (0.63) | KIF11TSHRLMNATYRRARB | |
| SCHEMBL13729097 | 0.89 | SMN1; SMN2 (0.46) | KIF11TSHRLMNATYRRARB | |
| SCHEMBL28297150 | 0.84 | PTPN1 (0.45) | KIF11TSHRRARBRARGPTPN1 | |
| SCHEMBL5181294 | 0.84 | ESR1 (0.46) | KIF11TSHRPTPN1HDAC8GABRP | |
| SCHEMBL450726 | 0.83 | PTPN1 (0.48) | KIF11RARBRARGPTPN1HDAC8 | |
| SCHEMBL201758 | 0.80 | PTPN1 (0.47) | KIF11TSHRLMNATYRRARB | |
| SCHEMBL17729292 | 0.80 | PDE2A (0.45) | KIF11RARBRARGPTPN1HDAC8 | |
| SCHEMBL25413986 | 0.78 | RARB (0.65) | KIF11TSHRLMNATYRRARB | |
| SCHEMBL19875742 | 0.78 | KIF11 (0.56) | KIF11TSHRLMNATYRRARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120132861-A | Copper-based high-entropy alloy material and preparation method and application thereof | 温州大学新材料与产业技术研究院 | 2025-06-13 | — | — | CN | claimed |
| CN-120028308-A | Small molecule Raman probe, bar code probe, encoding method and application thereof | 北京大学 | 2025-05-23 | — | — | CN | claimed |
| CN-115838382-B | Synthesis method of beta-ketophosphorus oxide | 惠州学院 | 2025-03-04 | — | — | CN | claimed |
| CN-118638088-B | Preparation method for synthesizing flavonoid compounds based on carbon dioxide and alkyne | 湖南工程学院 | 2024-11-22 | — | — | CN | claimed |
| CN-118515716-A | NNN-pyridine-quinoline cobalt complex, preparation method and catalytic alkyne hydrosilylation reaction | 石河子大学 | 2024-08-20 | — | — | CN | claimed |
| US-20240243010-A1 | INHIBITOR FOR SELECTIVELY DEPOSITING THIN FILM AND METHOD FOR SELECTIVELY DEPOSITING THIN FILM | ADEKA CORPORATION (JP) | 2024-07-18 | — | — | US | claimed |
| CN-117646229-A | Method for preparing ammonia by catalyzing NO through ultra-small copper nanoclusters | 广州惠清环保技术有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-115025820-B | Alkynyl borohydride catalyst and application thereof in alkynyl borohydride | 安徽大学 | 2023-11-14 | — | — | CN | claimed |
| CN-116969821-A | Method for photo-thermal catalysis of hydration carbonylation reaction of 4-tert-butyl phenylacetylene by using carbon nano tube | 南京工业大学 | 2023-10-31 | — | — | CN | claimed |
| CN-113788765-B | Preparation method of alpha, beta-unsaturated amide | 湖南工程学院 | 2023-08-15 | — | — | CN | claimed |
| EP-2729184-A1 | NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM | Institut National de la Recherche Scientifique (CA) | 2014-05-14 | — | — | EP | claimed |
| US-20140113872-A1 | NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2014-04-24 | — | — | US | claimed |
| EP-2013171-B1 | PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER S DISEASE | MERCK SHARP & DOHME (GB) | 2013-05-15 | — | — | EP | claimed |
| WO-2012149644-A1 | NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2012-11-08 | — | — | WO | claimed |
| EP-1599201-B1 | SELECTIVE NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS | MERCK SHARP & DOHME (US) | 2010-04-14 | — | — | EP | claimed |
| US-7109377-B2 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2006-09-19 | — | — | US | claimed |
| US-20030082830-A1 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-05-01 | — | — | US | claimed |
| US-6448443-B1 | GENERATED FROM DIVERSIFIABLE SCAFFOLDS SYNTHESIZED FROM THE PYRIDINE-BASED TEMPLATE ISONICOTINAMIDE; ALSO PROVIDES A NOVEL ORTHO-NITROBENZYL PHOTOLINKER; SYNTHESIZED FROM A SHIKIMIC ACID BASED EPOXYOL TEMPLATE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2002-09-10 | — | — | US | claimed |
| WO-2000006525-A9 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | HARVARD COLLEGE (US) | 2000-04-20 | — | — | WO | claimed |
| WO-2000006525-A2 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-02-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140113872-A1 | NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM | UTS2R, SCTR, PLAUR | KIF11 3628/4885TSHR 340/4885LMNA 3763/4885 |
| US-20030082830-A1 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | TKFC, NISCH, PTGIS | KIF11 2864/4885TSHR 4277/4885LMNA 4480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.